FDA inspection
Boehringer Ingelheim Pharma GmbH & Co. Kg: FDA inspection ending Jul 22, 2022
FDA inspection 1208927 · Voluntary Action Indicated (VAI) · Biberach An Der Riss
Key facts
| Inspection ID | 1208927 |
|---|---|
| Firm | Boehringer Ingelheim Pharma GmbH & Co. Kg |
| FEI number | 3002806518 |
| Address | Boehringer Ingelheim Pharma Gmbh & Co. Kg, Birkendorfer Str. 65 |
| City | Biberach An Der Riss |
| Country | Germany |
| Fiscal year | 2022 |
| Inspection end date | Jul 22, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data